RT Journal Article
SR Electronic
T1 Gynecologic Cancer InterGroup (GCIG) Consensus Review for Vulvovaginal Melanomas
JF International Journal of Gynecologic Cancer
JO Int J Gynecol Cancer
FD BMJ Publishing Group Ltd
SP S117
OP S122
DO 10.1097/IGC.0000000000000198
VO 24
IS Supp 3
A1 Mario M. Leitao
A1 Xi Cheng
A1 Anne L. Hamilton
A1 Nadeem A. Siddiqui
A1 Ina Jurgenliemk-Schulz
A1 Sven Mahner
A1 Elisabeth Åvall-Lundqvist
A1 Kidong Kim
A1 Gilles Freyer
YR 2014
UL http://ijgc.bmj.com/content/24/Supp_3/S117.abstract
AB Abstract Vulvovaginal melanomas are rare tumors that account for a small fraction of all vulvovaginal cancers. Biologically, they seem to be similar to mucosal and acral melanomas of other sites. There are limited data specific to vulvovaginal melanomas, especially regarding systemic therapies. Most treatment decisions are based on extrapolation from data regarding cutaneous melanomas of other sites. It is reasonable to follow already established guidelines from other professional groups and societies. Outcomes tend to be worse compared with cutaneous melanomas likely because of the later presentation and physical biological characteristics of these tumors.